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[Abstract] Cancer-associated fibroblasts (CAFs) are one of the major players in tumor-stroma 
crosstalk. Findings in experimental studies suggest important roles for CAFs in regulation of 
tumor growth, metastasis and drug response (Hanahan and Coussens, 2012). Furthermore, 
their clinical relevance is supported by new findings from tumor analyses, demonstrating the 
prognostic and response-predictive significance of CAF-derived markers or gene signatures 
(Berdiel-hacer et al., 2014; Finak et al., 2008; Navab et al., 2011; Paulsson and Micke, 2014). 
CAFs are a heterogeneous pool of cell subsets with distinct functions which needs to be better 
defined by their marker expressions. The development of a methodology for the establishment 
of fibroblast primary cultures derived from human colon tumors allowed us to characterize their 
functional and molecular properties (Herrera et al., 2013). In addition, the different molecular 
mechanisms through which CAFs affect tumor growth and metastasis are still to be clarified. 
Therefore, functional and molecular characterization of the cancer-associated fibroblasts is 
essential to fully understand their role in tumor progression. 
 
Materials and Reagents 
 
1. 50 ml Falcon tubes  
2. Sterile disposable plastic Pasteur pipettes or sterile forceps 
3. 10 cm tissue culture dishes 
4. T-25 tissue culture flasks 
5. MW6 tissue culture plates (Jet Biofil, catalog number: TCP-011-006) 
6. Human tissue samples (colon normal and tumor tissue) 
7. Dulbecco’s Modified Eagle Medium (DMEM) high glucose without L-glutamine (Lonza, 
catalog number: BE12-614F) 
8. L-glutamine (Lonza, catalog number: BE17-605E) 
9. Normocin™ (InvivoGen, catalog number: ANT-NR-2)    
10. Penicillin/Streptomycin (Lonza, catalog number: BE17-602E) 
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11. Amphotericin B (Carl Roth GmbH + Co., catalog number: 0246.1) 
12. Gentamicin (Carl Roth GmbH + Co., catalog number: 0233.2) 
13. Phosphate-buffered saline (PBS) (Lonza, catalog number: BE17-516F)  
14. Fetal Bovine Serum medium (FBS) (Biowest, catalog number: S181B-500) 
15. Trypsin/EDTA (Thermo Fisher Scientific, GibcoTM, catalog number: 25200-056) 
16. FBM & FGM-2 Bullet kit  [Lonza, catalog number:(CC-3131) and (CC-4126)] 
Note: FBM & FGM-2 Bullet kit is on the list of Fibroblast Growth Media (FGM) Kits] 
(Lonza, catalog number: CC-3132). 
17. DMEM (see Recipes) 
18. FBS with high concentration of antibiotics (see Recipes) 
19. FBS with normal concentration of antibiotics (see Recipes) 
 
Equipment 
 
1. Laminar flow tissue culture hood 
2. Scalpels 
3. 37 °C shaker 
4. 37 °C and 5% CO2 cell culture incubator 
5. Centrifuge 
 
Procedure 
 
A. Before starting 
1. Immediately after surgery, colon normal and tumor tissues are preserved in Falcon 
tubes with 10 ml of DMEM with a high concentration of antibiotics to avoid bacterial or 
fungal contamination. To this end, DMEM is supplemented with 5% FBS, L-glutamine 
(1%), 300 U/ml Penicillin, 300 µg/ml Streptomycin and 5 µg/ml Amphotericin B. 
2. Tissue samples are kept at 4 °C until use. It is recommended to minimize the time 
between the colon surgery and the processing of the sample. 
3. Make sure that you have all the necessary materials, reagents and equipment. 
 
B. Washing samples: Normal mucosa and tumor material 
1. Falcon tubes with human tissue samples from colon tumor or normal mucosa are 
placed into a laminar flow tissue culture hood under sterile conditions. The average 
size of tissues required is 1 cm2. 
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Figure 1. Surgical colon human samples. Representative images of tumor tissue 
sample to show the used average size.  
 
2. Perform two quick washes of the tissue samples with 10 ml PBS each time using 
Falcon tubes and Pasteur pipettes to handle the samples. 
3. Then, incubate the samples for 30 min in 10 ml of PBS with 0.5 mg/ml Normocin, 0.5 
µg/ml Amphotericin B and 0.1 mg/ml Gentamicin in the Falcon tubes. Shake gently in 
a 37 °C shaker. 
 
C. Dissecting and seeding samples: Normal mucosa and tumor material 
1. Tissue samples are transferred to a 10 cm tissue culture dish. Do not let the samples 
dry out at this point. 
2. The samples are carefully analyzed: normal tissue is fatty and soft, while tumor tissue 
is stiff, multimodular to variable degrees, and sometimes displays more irrigated 
areas.  
3. Cut the tissue samples into pieces of approximately 2-3 mm3 by scalpels. 
4. Use Pasteur pipettes or sterile forceps to seed tissue pieces in T-25 tissue culture 
flasks with 2 ml of FBS supplemented with 0.2 mg/ml Normocin, 200 U/ml Penicillin, 
200 µg/ml Streptomycin and 0.1 mg/ml Gentamicin (Hanahan and Coussens, 2012). 
We call this medium "FBS with high concentration of antibiotics". Incubate the 
T-25 flasks at 37 °C in a humid atmosphere containing 5% CO2. 
5. After 24 h, it is quite useful to remove culture medium from the T-25 flasks, wash twice 
with PBS, and add fresh “FBS with high concentration of antibiotics” medium. When 
changing the medium, be careful and try to keep the pieces stuck on the plate. If after 
two days bacterial or fungal contamination does not appear, it is optional to change 
the medium to "FBS with normal concentration of antibiotics" (Berdiel-hacer et al., 
2014): FBS with 0.1 mg/ml Normocin, 100 U/ml Penicillin and 100 µg/ml Streptomycin. 
However, if contamination persists, continue using "FBS with high concentration of 
antibiotics". If after five days contamination has not disappeared, discard the samples. 
6. Normally, outgrowths of fibroblasts appear after 10 days and the culture medium is 
replaced by FBM supplemented with FGM-2 Bulletkit to facilitate fibroblast growth 
(Finak et al., 2008). The fibroblastic cells are routinely maintained in FBM medium at 
37 °C in a humid atmosphere containing 5% CO2. Change the medium every two 
days. 
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D. Expansion of fibroblast primary cell cultures  
1. After 30-40 days, when the cell culture is usually quite large (see Figure 1), the 
remnants of the tissue are removed giving a light tap to the flask. 
2. Fibroblasts are washed twice with PBS and trypsinized by Trypsin/EDTA for 5 min at 
37 °C. Use serum medium (FBS) to block the trypsin activity and centrifuge at 1,200 
rpm during 5 min. After that, seed the fibroblasts cells in MW6 tissue plates using FBM 
medium. 
3. Then, fibroblast primary cultures are subcultured at a 1 to 2 ratio (Navab et al., 2011) 
in FBM medium and maintained at 37 °C in a humid atmosphere containing 5% CO2. 
Change the medium every two days. Primary CAFs initially show bi- and/or multi-polar 
morphology and then acquired a uniform spindle-shaped morphotype and formed 
parallel arrays and whorls at confluence. Expression of α-sma and Vimentin and the 
absence of Pan Cytokeratin (PanCK) could be analyzed by immunofluorescence to 
verify the CAF enrichment in the cell culture as was done in Herrera et al. (2013). 
 
 
Figure 2. Establishment and characterization of primary CAFs from colon 
cancer patients. Representative images of CAF cultures along the establishment 
time. Scale bar=50 μm 
 
Recipes 
 
1. DMEM 
5% FBS 
L-glutamine (1%) 
300 U/ml Penicillin 
300 µg/ml Streptomycin  
2. 5 µg/ml Amphotericin BFBS with high concentration of antibiotics 
FBS supplemented with 0.2 mg/ml Normocin, 200 U/ml Penicillin, 200 µg/ml 
Streptomycin and 0.1 mg/ml Gentamicin (Hanahan and Coussens, 2012) 
3. FBS with normal concentration of antibiotics 
FBS with 0.1 mg/ml Normocin, 100 U/ml Penicillin and 100 µg/ml Streptomycin 
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Notes 
 
1. We recommend not putting more than 5-6 pieces in each T25 flask, which helps 
control contamination. Use several flasks per sample if you need to do so. 
2. We prefer to use the medium "FBS with high concentration of antibiotics" for 7-10 days 
(replace with fresh medium every two days).  
3. We recommend changing the medium to FBM after 12-14 days even if fibroblasts are 
not seen. 
4. Cell numbers can be expanded minimally, though bear in mind that primary cells enter 
senescence after prolonged in vitro culture. Immortalization can be performed using 
adequate procedures (Navab et al., 2011). 
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